5-Minute Focus: What the New EULAR-ACR Classification Criteria Mean for Antiphospholipid Syndrome
The Wellness Pharmacist di Dr. Kat Holt
Note sull'episodio
Today on The Wellness Pharmacist with Dr. Kat, we’re taking a closer look at an important study published in The Lancet Rheumatology in March 2025.
Key Takeaways from the Study
🔹Improved Precision for Pregnant Individuals with APS
🔹 Not a Diagnostic Tool for Routine Clinical Use
🔹 Advancing Research & Treatment
Listener Question:
📞 “Hi Dr. Kat, I’ve had multiple miscarriages, but my doctor never mentioned APS. Should I ask to be tested?”
Parole chiave
Dr. KatHealth podcastRheumatologyThe Wellness Pharmacistantiphospholipid syndromeAPS and pregnancyAPS diagnosisRecurrent miscarriage causesBlood clotting disordersAPS treatment updatesThe Lancet Rheumatology studypregnancy and autoimmune diseasesprecision medicine in rheumatologyMiscarriages and APSAPSPregnancy healthrecurrent miscarriageThe Lancet studyprecision medicine